Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Benchmark Initiates Coverage On Know Labs with Speculative Buy Rating, Announces Price Target of $1

Author: Benzinga Newsdesk | April 08, 2024 08:03am
Benchmark analyst Bruce Jackson initiates coverage on Know Labs (AMEX:KNW) with a Speculative Buy rating and announces Price Target of $1.

Posted In: KNW

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist